Blood glucose: Measurement in the point-of-care setting

Laboratory Medicine

Volumn 31, Issue 5, 2000, Pages 276-282

  Kiechle, Frederick L ^a   Main, Rhonda Ingram ^a  

^a WILLIAM BEAUMONT HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

DIABETES CONTROL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HOME CARE; HOSPITAL CARE; HUMAN; MEDICAL TECHNOLOGY; PATIENT MONITORING; QUALITY CONTROL; REVIEW;

EID: 0034122945     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/4BF1-ET6T-WFE3-M7XA     Document Type: Review

References (44)

1. American Diabetes Association. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183-1197.
2. Harris MI. Impaired glucose tolerance in the US population. Diabetes Care. 1989;12:464-474.
3. Hodgson TA, Cohen AJ. Medical care expenditures for diabetes, its chronic complications, and its comorbidities. Prev Med. 1999;29:173-186.
4. Lee-Lewandrowski E, Laposata M, Eschenbach K, et al. Utilization and cost analysis of bedside capillary glucose testing in a large teaching hospital: implications for managing point of care testing. Am J Med. 1994;97:222-230.
5. NCCLS. Guidelines for Ancillary (Bedside) Blood Glucose Testing in Acute and Chronic Care Facilities; C30-A. Wayne, Pa: NCCLS; 1994.
6. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications, I: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-553.
7. Davies M. New diagnostic criteria for diabetes: are they doing what they should? Lancet. 1999;354:610-611.
8. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
9. UK Prospective Diabetes Study Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
10. UK Prospective Diabetes Study Group. Effect of intensive blood glucose control policy with metformin on complications in type 2 diabetes patients (UKPDS 34). Lancet. 1998;352:854-865.
11. Kiechle FL. Point-of-care Testing. Rainey P, ed. Washington DC: AACC Press; 1998:1-98.
12. Evans JMM, Newton RW, Ruta DA, et al. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ. 1999;319:83-86.
13. Rindone JP. Restricting home glucose-monitoring strips in patients taking oral antidiabetic agents. Am J Health Syst Pharm. 1998;55:2509-2511.
14. Weitgasser R, Gappmayer B, Pichler M. Newer portable glucose meters: analytical improvement compared with previous generation devices? Clin Chem. 1999;45:1821-1825.
15. Belsey R, Morrison JI, Whitlaw KJ, et al. Managing bedside glucose testing in the hospital. JAMA. 1987;258:1634-1638.
16. Cembrowski GS, Kiechle FL. Point-of-care testing: critical analysis and practical application. Adv Pathol Lab Med. 1994;7:3-26.
17. Lum G. Assessment of a critical limit protocol for point-of-care glucose testing. Am J Clin Pathol. 1996;106:390-395.
18. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med. 1997;157:545-552.
19. Sacks DM. Carbohydrates. In: Ashwood ER, ed. Tietz Textbook of Clinical Chemistry. 3rd ed. Philadelphia, PA: Saunders; 1999:750-808.
20. Turner APF, Chen B, Piletsky SA. In vitro diagnostics in diabetes: meeting the challenge. Clin Chem. 1999;45:1596-1601.
21. Atkin SH, Dasmaphapatra A, Jaker MA, et al. Fingerstick glucose determination in shock. Ann Intern Med. 1991;14:1020-1024.
22. Maser RE, Butler MA, DeCherney GS. Use of arterial blood with bedside glucose reflectance meters in an intensive care unit: are they accurate? Crit Care Med. 1994;22:595-599.
23. Tamada JA, Garg S, Jovanovic L, et al. Noninvasive glucose monitoring: comprehensive clinical results. JAMA. 1999;282:1839-1844.
24. Garg SK, Potts RO, Ackerman NR, et al. Correlation of fingerstick blood glucose measurements with GlucoWatch biographer glucose results in young subjects with type 1 diabetes. Diabetes Care. 1999;22:1708-1714.
25. Hazard Report: Errors in using blood glucose monitors in hospitals. Health Devices. 1996;25:147-148.
26. Young DS. Effects of Drugs on Clinical Laboratory Tests. 4th ed. Washington, DC: AACC Press; 1995;3:374-391.
27. Keeling AB, Schmidt P. Dopamine influence on whole-blood glucose reagent strips [letter]. Diabetes Care. 1987;10:532.
28. Barreau PB, Buttery JE. The effect of haematocrit on the determination of glucose levels by reagent strip methods. Med J Aust. 1987;147:286-288.
29. Sweet DG, Madden D, Halliday HL. The effect of early feeding on the neonatal blood glucose level at 1-hour of age. Early Hum Dev. 1999;55:63-66.
30. Chun T-Y, Hirose M, Sawa T, et al. The effect of the partial pressure of oxygen on blood glucose concentration examined using glucose oxidase with ferricyan ion. Anesth Analg. 1994;79:993-997.
31. Kurahashi K, Maruta H, Usuda Y, et al. Influence of blood sample oxygen tension on blood glucose concentration using an enzyme-electrode method. Crit Care Med. 1997;25:231-235.
32. Kost GJ, Vu H-T, Lee JH, et al. Multicenter study on oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada. Crit Care Med. 1998;26:581-590.
33. Valazques FR, Altaffer M. Testing of arterial blood with the new Medisense blood glucose monitoring system [abstract]. Ann Clin Lab Sci. 1996;26:366.
34. Bavek T, Kazokoglu H, Temel A. Intraocular pressure variations during extracorporeal circulation and some influencing factors. Thorac Cardiovasc Surg. 1991;39:29-31.
35. Karcher RE, Ingram RL, Kiechle FL, et al. Comparison of the HemoCue beta-glucose photometer and reflotron for open heart surgery. Am J Clin Pathol. 1993;100:130-134.
36. Main RI, Wright J, Kiechle FL. Data management programs for bedside glucose testing. Lab Med. 1994;25:784-789.
37. Chance JJ, Li DJ, Jones KA, et al. Technical evaluation of five glucose meters with data management capabilities. Am J Clin Pathol. 1999;111:547-556.
38. Kiechle FL. At the bedside: POCT data management. Advance for Laboratory Administrators. 1997;6:10-11.
39. Tussen RG, Kaptein WA, Venema K, et al. Slow ultrafiltration for continuous in vivo sampling: application for glucose and lactate in man. Anal Chim Acta. 1999;379:327-335.
40. Khalil OS. Spectroscopic and clinical aspects of noninvasive glucose measurements. Clin Chem. 1999;45:165-177.
41. Malin SF, Ruchti TL, Blank TB, et al. Noninvasive prediction of glucose by near-infrared diffuse reflectance spectroscopy. Clin Chem. 1999;45:1651-1658.
42. Burmeister JJ, Arnold MA. Evaluation of measurement sites for noninvasive blood glucose sensing with near-infrared transmission spectroscopy. Clin Chem. 1999;45:1621-1627.
43. MacKenzie HA, Ashton HS, Spiers S, et al. Advances in photoacoustic noninvasive glucose testing. Clin Chem. 1999;45:1587-1595.
44. Coss-Bu JA, Jefferson LS, Stone-McCord S, et al. Evaluation of a real time blood glucose monitor in children with diabetic ketoacidosis. Diabetes Res Clin Pract. 1999;44:175-181.